GlassScriptPhysician profile
Richard Wexler
NPI 1679625362
$4,307.79
in general payments reported to CMS, 2019-2025
32 companies · $703 in 2025
The $703 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,662 · 2020: $260 · 2021: $201 · 2022: $204 · 2023: $371 · 2024: $907 · 2025: $703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,976 · Travel and Lodging: $5.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,975.63 |
| Travel and Lodging | $5.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $732.38 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $545.63 | 2019-2023 | Xarelto |
| Abbvie INC. | $512.75 | 2019-2024 | Ubrelvy |
| Amgen INC. | $498.05 | 2019-2025 | Repatha, Repatha, Otezla |
| Abbott Laboratories | $308.11 | 2024-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $279.23 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $192.93 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Inari Medical, INC. | $176.73 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Inspire Medical Systems, INC. | $149.12 | 2024-2025 | Inspire |
| Amarin Pharma, INC. | $147.30 | 2019-2021 | |
| Phathom Pharmaceuticals, INC. | $116.31 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $69.70 | 2019-2020 | |
| Thd America, INC. | $68.92 | 2019 | |
| Pfizer INC. | $61.34 | 2019-2023 | |
| Esperion Therapeutics, INC. | $48.30 | 2021-2024 | Nexletol |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $47.00 | 2021 | |
| Sanofi Pasteur INC. | $37.73 | 2019-2023 | |
| Circassia INC. | $30.51 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $24.94 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.68 | 2019 | |
| Exact Sciences Corporation | $23.51 | 2025 | Cologuard Collection Kit |
| Lundbeck LLC | $23.12 | 2019 | |
| Seqirus USA INC | $23.00 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Intercept Pharmaceuticals, INC. | $22.77 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.33 | 2025 | Jardiance |
| Glaxosmithkline, LLC. | $21.67 | 2024 | Shingrix, Arexvy |
| Shire North American Group INC | $20.18 | 2019 | |
| Astellas Pharma US INC | $18.77 | 2019 | |
| Ironwood Pharmaceuticals, INC | $18.61 | 2020 | |
| Currax Pharmaceuticals LLC | $16.01 | 2025 | Contrave |
| E.R. Squibb & Sons, L.L.C. | $13.85 | 2019 | |
| Allergan, INC. | $13.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Wexler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.